II-B08 is a reversible and noncompetitive SHP2 inhibitor ( IC 50 : 5.5 μM, 15.7, 14.3 μM for SHP2 , SHP1, PTP1B). II-B08 can be used for cancer research.
Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > SHP2 | Products > Signaling Pathways > SHP1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.